Crinetics Pharmaceuticals (CRNX) Competitors $30.99 +0.34 (+1.11%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$31.12 +0.13 (+0.42%) As of 08/29/2025 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRNX vs. QGEN, MRNA, BBIO, ELAN, VRNA, ROIV, GRFS, RVMD, RYTM, and LEGNShould you be buying Crinetics Pharmaceuticals stock or one of its competitors? The main competitors of Crinetics Pharmaceuticals include QIAGEN (QGEN), Moderna (MRNA), BridgeBio Pharma (BBIO), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), Grifols (GRFS), Revolution Medicines (RVMD), Rhythm Pharmaceuticals (RYTM), and Legend Biotech (LEGN). These companies are all part of the "pharmaceutical products" industry. Crinetics Pharmaceuticals vs. Its Competitors QIAGEN Moderna BridgeBio Pharma Elanco Animal Health Verona Pharma PLC American Depositary Share Roivant Sciences Grifols Revolution Medicines Rhythm Pharmaceuticals Legend Biotech Crinetics Pharmaceuticals (NASDAQ:CRNX) and Qiagen (NYSE:QGEN) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends. Which has more risk & volatility, CRNX or QGEN? Crinetics Pharmaceuticals has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Comparatively, Qiagen has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500. Do institutionals and insiders believe in CRNX or QGEN? 98.5% of Crinetics Pharmaceuticals shares are owned by institutional investors. Comparatively, 70.0% of Qiagen shares are owned by institutional investors. 6.0% of Crinetics Pharmaceuticals shares are owned by company insiders. Comparatively, 9.0% of Qiagen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts recommend CRNX or QGEN? Crinetics Pharmaceuticals presently has a consensus target price of $68.86, indicating a potential upside of 122.19%. Qiagen has a consensus target price of $49.69, indicating a potential upside of 6.77%. Given Crinetics Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Crinetics Pharmaceuticals is more favorable than Qiagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crinetics Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.78Qiagen 0 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.27 Is CRNX or QGEN more profitable? Qiagen has a net margin of 18.30% compared to Crinetics Pharmaceuticals' net margin of 0.00%. Qiagen's return on equity of 14.77% beat Crinetics Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Crinetics PharmaceuticalsN/A -32.28% -29.45% Qiagen 18.30%14.77%8.87% Does the media favor CRNX or QGEN? In the previous week, Qiagen had 13 more articles in the media than Crinetics Pharmaceuticals. MarketBeat recorded 24 mentions for Qiagen and 11 mentions for Crinetics Pharmaceuticals. Crinetics Pharmaceuticals' average media sentiment score of 1.51 beat Qiagen's score of 0.90 indicating that Crinetics Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crinetics Pharmaceuticals 9 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Qiagen 8 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation & earnings, CRNX or QGEN? Qiagen has higher revenue and earnings than Crinetics Pharmaceuticals. Crinetics Pharmaceuticals is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCrinetics Pharmaceuticals$1.04M2,806.38-$298.41M-$4.11-7.54Qiagen$2.04B5.07$83.59M$1.6927.53 SummaryQiagen beats Crinetics Pharmaceuticals on 10 of the 16 factors compared between the two stocks. Get Crinetics Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRNX vs. The Competition Export to ExcelMetricCrinetics PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.92B$2.51B$5.71B$9.77BDividend YieldN/A48.51%6.66%4.48%P/E Ratio-7.5422.6183.2526.60Price / Sales2,806.38731.65538.85112.37Price / CashN/A26.3325.6628.92Price / Book2.175.3710.646.08Net Income-$298.41M$32.95M$3.27B$265.93M7 Day Performance0.23%-1.28%0.40%0.17%1 Month Performance8.39%5.64%7.31%3.90%1 Year Performance-41.59%-3.15%46.58%19.67% Crinetics Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRNXCrinetics Pharmaceuticals3.7129 of 5 stars$30.99+1.1%$68.86+122.2%-41.6%$2.92B$1.04M-7.54210News CoveragePositive NewsInsider TradeQGENQIAGEN3.799 of 5 stars$48.92-1.6%$49.69+1.6%+4.8%$11.06B$1.98B28.905,765Trending NewsAnalyst RevisionMRNAModerna4.5122 of 5 stars$25.35-6.5%$42.88+69.2%-68.9%$10.55B$3.24B-3.375,800BBIOBridgeBio Pharma4.2489 of 5 stars$47.29-3.6%$61.35+29.7%+85.9%$9.38B$221.90M-11.56400News CoveragePositive NewsAnalyst ForecastELANElanco Animal Health2.7747 of 5 stars$17.80-0.6%$17.33-2.6%+18.8%$8.90B$4.48B20.709,000VRNAVerona Pharma PLC American Depositary Share2.4247 of 5 stars$105.62+0.1%$109.00+3.2%+285.4%$8.64B$221.67M-106.6930Positive NewsROIVRoivant Sciences3.1641 of 5 stars$11.64-2.3%$16.50+41.8%-2.5%$8.14B$29.05M-16.63860News CoveragePositive NewsGRFSGrifols3.5505 of 5 stars$9.82-3.3%$10.30+4.9%+6.7%$6.99B$7.81B8.3923,822RVMDRevolution Medicines4.3496 of 5 stars$35.67-3.6%$69.92+96.0%-10.9%$6.92BN/A-7.93250News CoveragePositive NewsRYTMRhythm Pharmaceuticals3.5913 of 5 stars$99.20-3.9%$101.57+2.4%+118.1%$6.86B$130.13M-32.96140News CoveragePositive NewsLEGNLegend Biotech3.7846 of 5 stars$34.60-2.7%$73.00+111.0%-39.7%$6.53B$627.24M-39.322,609News CoverageAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies QIAGEN Competitors Moderna Competitors BridgeBio Pharma Competitors Elanco Animal Health Competitors Verona Pharma PLC American Depositary Share Competitors Roivant Sciences Competitors Grifols Competitors Revolution Medicines Competitors Rhythm Pharmaceuticals Competitors Legend Biotech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRNX) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRNX Stock Alerts